| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |